Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenecteplase for Distal MeVO Stroke Beyond Time Window
NCT06559436Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Oct 2024
- Primary completion
- Sep 2026
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Randomised, open-label trial of tenecteplase in ischemic stroke (2 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoint: Rates of 90 day good functional outcomes. Started Oct 2024; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06559436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06559436.